{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:28:21Z","timestamp":1792686501534,"version":"4.5.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Thrombosis and inflammation are closely interconnected. Systemic inflammation activates the coagulation system, while components of the coagulation system can, in turn, significantly influence the inflammatory response. This process, where the immune system contributes to thrombus formation, is known as immunothrombosis. Conversely, thromboinflammation describes the effect of thrombus formation on the immune system. Various immune cells, including neutrophils and monocytes, play key roles in these processes, as well as endothelial cells, strategically positioned to rapidly detect and respond to invading pathogens. Platelets are also actively recruited, promoting coagulation and releasing procoagulant factors. When the endothelium becomes dysfunctional and acquires proinflammatory and procoagulant properties, it fosters the formation of microvascular thrombosis. The excessive release of proinflammatory cytokines and chemokines further intensifies this cycle, contributing to cytokine storms, as observed in severe COVID-19 cases. This phenomenon exemplifies immunothrombosis and thromboinflammation. Anticoagulant therapy is standard care for venous thromboembolism prevention in Intensive Care Unit patients, with critically ill COVID-19 patients often receiving higher doses. However, variations in individual responses to heparin were observed in COVID-19 patients, suggesting a degree of resistance to anticoagulant therapy. This resistance may be linked to thromboinflammation, where the intense inflammatory response diminishes the effectiveness of anticoagulation. In this context, combining anticoagulants with immunomodulatory drugs has shown promising potential. This review aims to delve into the concepts of immunothrombosis and thromboinflammation, with a particular focus on the complex interplay between the coagulation and inflammation systems and their mutual reinforcement in the context of COVID-19. We examine why standard anticoagulant therapies often proved insufficient in managing hyperinflammatory diseases and discuss potential alternative treatment strategies. Furthermore, we evaluate the potential role of rotational thrombelastometry (ROTEM) in managing immunothrombotic states.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1599639","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:13:42Z","timestamp":1750292022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not?"],"prefix":"10.3389","volume":"16","author":[{"given":"Lou M.","family":"Almskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri2532","article-title":"Intravascular immunity: the host\u2013pathogen encounter in blood vessels","volume":"9","author":"Hickey","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","volume":"14","author":"Maneta","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.679878","article-title":"COVID-19: lung-centric immunothrombosis","volume":"11","author":"Kvietys","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838011","article-title":"NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.htct.2023.05.008","article-title":"Immunothrombosis and its underlying biological mechanisms","volume":"46","author":"De Nardi","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijms232113176","article-title":"Immunothrombosis and the role of platelets in venous thromboembolic diseases","volume":"23","author":"Heestermans","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2178-6491","article-title":"The concept of thromboinflammation","volume":"44","author":"Schrottmaier","year":"2024","journal-title":"H\u00e4mostaseologie"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0082-y","article-title":"The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies","volume":"2","author":"Lundberg","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejcb.2012.01.003","article-title":"Cytokines and inflammation","volume":"91","author":"Floege","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.185785","article-title":"Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase","volume":"104","author":"Blair","year":"2009","journal-title":"Circ Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-343566","article-title":"Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow","volume":"118","author":"Zarbock","year":"2011","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cpcy.8","article-title":"Whole blood analysis of leukocyte-platelet aggregates","volume":"78","author":"Gerrits","year":"2016","journal-title":"Curr Protoc Cytom"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026016628386","article-title":"Platelet endothelial cell adhesion molecule in cell signaling and thrombosis","volume":"253","author":"Gong","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15852","article-title":"Intracellular communication and immunothrombosis in sepsis","volume":"20","author":"Iba","year":"2022","journal-title":"J Thromb Hemost"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000463","article-title":"Communication is key: mechanisms of intercellular signaling in vasodilation","volume":"69","author":"Freed","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"B23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cytogfr.2021.10.007","article-title":"Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism","volume":"63","author":"Ahmad","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201910-1911TR","article-title":"Endothelial responses in sepsis","volume":"202","author":"Joffre","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B25","article-title":"Antiphospholipid syndrome\u2013not a noninflammatory disease","volume":"41","author":"De Groot","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318225","article-title":"Inflammation, infection and venous thromboembolism","volume":"128","author":"Colling","year":"2021","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.09.042","article-title":"Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis","volume":"171","author":"Iba","year":"2018","journal-title":"Thromb Res"},{"key":"B28","first-page":"401","article-title":"Blood Vessels and Endothelial Cells","volume-title":"Molecular Biology of the Cell","author":"Alberts","year":"2003"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1078\/1438-4221-00128","article-title":"Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses","volume":"291","author":"Kirschning","year":"2001","journal-title":"Int J Med Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20210522","article-title":"Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants","volume":"479","author":"Ryan","year":"2022","journal-title":"Biochem J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-center, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Hematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7326\/L20-1206","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"crossref","first-page":"e20200128","DOI":"10.1590\/1677-5449.200128","article-title":"Physiopathology of SARS-coV-2-infection-associated thrombosis","volume":"19","author":"Casella","year":"2020","journal-title":"J Vasc Bras"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-01-0053","article-title":"The coagulation system and its function in early immune defense","volume":"112","author":"Poll","year":"2014","journal-title":"Thromb Hemost"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101094","article-title":"Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica","author":"Luo","year":"2011","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jtha.2023.07.020","article-title":"Thromboinflammation in acute injury: infections, heatstroke, and trauma","volume":"22","author":"Iba","year":"2024","journal-title":"J Thromb Hemost"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07873-4","article-title":"Fibrin drives thromboinflammation and neuropathology in COVID-19","author":"Ryu","year":"2024","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902810","article-title":"Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1","volume":"184","author":"Hamad","year":"2010","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(98)80030-2","article-title":"Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis","volume":"199","author":"Peerschke","year":"1998","journal-title":"Immunobiology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000605","article-title":"The interaction between the complement system and hemostatic factors","volume":"27","author":"Oncul","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"De Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defense system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.12.002","article-title":"Targeting thromboinflammation in antiphospholipid syndrome","volume":"21","author":"Salet","year":"2023","journal-title":"J Thromb Hemost"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15359","article-title":"Differential regulation of the platelet GPIb-IX complex by anti-GPIb\u03b2 antibodies","volume":"19","author":"Quach","year":"2021","journal-title":"J Thromb Hemost"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"Van Der Meijden","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00070","article-title":"Are platelets cells? And if yes, are they immune cells","volume":"6","author":"Garraud","year":"2015","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2202","article-title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-\u03b1 production in vivo","volume":"107","author":"Aslam","year":"2006","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(16)30355-3","article-title":"Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome","volume":"141","author":"Van Geffen","year":"2016","journal-title":"Thromb Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.122.317162","article-title":"Thromboinflammation: from atherosclerosis to COVID-19","volume":"42","author":"Wagner","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e318181af2a","article-title":"TLR SIGNALING PATHWAY IN PATIENTS WITH SEPSIS","volume":"30","author":"Salom\u00e3o","year":"2008","journal-title":"Shock"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/biom11111550","article-title":"Mechanisms of immunothrombosis by SARS-coV-2","volume":"11","author":"Hern\u00e1ndez-Huerta","year":"2021","journal-title":"Biomolecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-020-08816-3","article-title":"Neutrophils in the pathogenesis of rheumatic diseases: fueling the fire","volume":"60","author":"Liu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-343061","article-title":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4","volume":"118","author":"Semeraro","year":"2011","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1159\/000489829","article-title":"Neutrophil extracellular traps in the second decade","volume":"10","author":"Brinkmann","year":"2018","journal-title":"J Innate Immun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ebiom.2021.103382","article-title":"Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation","volume":"67","author":"Englert","year":"2021","journal-title":"EBioMedicine"},{"key":"B73","article-title":"The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells","volume":"46","author":"van Furth","year":"1972","journal-title":"Bull World Health Organ"},{"key":"B74","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12156","article-title":"Tissue factor non-coagulant signaling \u2013 molecular mechanisms and biological consequences with a focus on cell migration and apoptosis","volume":"11","author":"\u00c5berg","year":"2013","journal-title":"J Thromb Hemost"},{"key":"B77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.thromres.2023.05.018","article-title":"Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis","volume":"228","author":"Musgrave","year":"2023","journal-title":"Thromb Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13265","article-title":"The influence of corticosteroids on hemostasis in healthy subjects","volume":"14","author":"Majoor","year":"2016","journal-title":"J Thromb Hemost"},{"key":"B79","first-page":"NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19 \u2014 Preliminary report","year":"2020","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00377-5","article-title":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomized, controlled trial","volume":"9","author":"Declercq","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00081-3","article-title":"Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicenter, randomized, controlled, phase 3 trial","volume":"9","author":"Soin","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1261-z","article-title":"Heparin: 100 years of pleiotropic effects","volume":"41","author":"Paschoa","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nrd724","article-title":"Novel drug development opportunities for heparin","volume":"1","author":"Lever","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"B87","doi-asserted-by":"publisher","first-page":"119818","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: An old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydr Polym"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"25984","DOI":"10.1038\/srep25984","article-title":"Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials","volume":"6","author":"Fan","year":"2016","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12871-021-01545-w","article-title":"Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis","volume":"22","author":"Fu","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J Thromb Hemost"},{"key":"B92","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)","volume":"9","author":"Egi","year":"2021","journal-title":"J Intensive Care"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw550","article-title":"Thrombosis and platelets: an update","author":"Koupenova","year":"2016","journal-title":"Eur Heart J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30411-2","article-title":"Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomized, double-blind, placebo-controlled primary prevention trial","volume":"9","author":"Eisen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform trial","volume":"399","author":"Abani","year":"2022","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non\u2013critically ill hospitalized patients with COVID-19: A randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216243","article-title":"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms","volume":"76","author":"Loo","year":"2021","journal-title":"Thorax"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","first-page":"ajh.25482","DOI":"10.1002\/ajh.25482","article-title":"The D-dimer assay","author":"Johnson","year":"2019","journal-title":"Am J Hematol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer level in COVID-19 infection: a systematic review","volume":"13","author":"Rostami","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2174\/1389450123666220826162900","article-title":"Fibrinogen, fibrin, and fibrin degradation products in COVID-19","volume":"23","author":"Kangro","year":"2022","journal-title":"Curr Drug Targets"},{"key":"B104","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/jcm10020191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy","volume":"10","author":"Iba","year":"2021","journal-title":"J Clin Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"Yang","year":"2020","journal-title":"J Thromb Hemost"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","author":"Spiezia","year":"2020","journal-title":"Thromb Hemost"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02130-7","article-title":"Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia","author":"Pavoni","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4097\/kja.21006","article-title":"The role of rotational thromboelastometry during the COVID-19 pandemic: A narrative review","author":"G\u00f6rlinger","year":"2021","journal-title":"Korean J Anesthesiol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618772336","article-title":"The double hazard of bleeding and thrombosis in hemostasis from a clinical point of view: A global assessment by rotational thromboelastometry (ROTEM)","volume":"24","author":"Akay","year":"2018","journal-title":"Clin Appl Thromb"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: Technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13049-016-0308-2","article-title":"A systematic review on the rotational thrombelastometry (ROTEM\u00ae) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients","volume":"24","author":"Veigas","year":"2016","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.03.021","article-title":"Application of ROTEM to assess hypercoagulability in patients with lung cancer","volume":"135","author":"Davies","year":"2015","journal-title":"Thromb Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7326\/0003-4819-104-6-810","article-title":"Diagnostic decision: diagnostic uses of the activated partial thromboplastin time and prothrombin time","volume":"104","author":"Suchman","year":"1986","journal-title":"Ann Intern Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"Han","year":"2020","journal-title":"Clin Chem Lab Med CCLM"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Hemost"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead571","article-title":"Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations","volume":"63","author":"Gaspar","year":"2024","journal-title":"Rheumatology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11926-014-0481-0","article-title":"The challenge of bleeding in antiphospholipid antibody-positive patients","volume":"17","author":"Pazzola","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B120","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/ijms25010668","article-title":"Catastrophic antiphospholipid syndrome","volume":"25","author":"Bitsadze","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.autrev.2015.08.011","article-title":"Delineating the deranged immune system in the antiphospholipid syndrome","volume":"15","author":"Van Den Hoogen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/art.v67.11","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: A newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/art.v72.12","article-title":"Anti\u2013neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B124","first-page":"66","article-title":"Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome","volume":"32","author":"Leffler","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"Lancet Microbe"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1599639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:13:44Z","timestamp":1750292024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1599639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2025.1599639"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1599639","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1599639"}}